These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36235137)

  • 21. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotechnical Evaluation by SeDeM Expert System to Develop Orodispersible Tablets.
    Rao MRP; Sapate S; Sonawane A
    AAPS PharmSciTech; 2022 May; 23(5):133. PubMed ID: 35534652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of carbamazepine-Soluplus solid dispersions by hot-melt extrusion, and prediction of drug-polymer miscibility by thermodynamic model fitting.
    Djuris J; Nikolakakis I; Ibric S; Djuric Z; Kachrimanis K
    Eur J Pharm Biopharm; 2013 May; 84(1):228-37. PubMed ID: 23333900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.
    Mohammed NN; Majumdar S; Singh A; Deng W; Murthy NS; Pinto E; Tewari D; Durig T; Repka MA
    AAPS PharmSciTech; 2012 Dec; 13(4):1158-69. PubMed ID: 22961411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downstream processing of amorphous solid dispersions into orodispersible tablets.
    Kokott M; Klinken S; Breitkreutz J; Wiedey R
    Int J Pharm; 2023 Jan; 631():122493. PubMed ID: 36528189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downstream processing from hot-melt extrusion towards tablets: A quality by design approach.
    Grymonpré W; Bostijn N; Herck SV; Verstraete G; Vanhoorne V; Nuhn L; Rombouts P; Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Oct; 531(1):235-245. PubMed ID: 28823887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of polymer carrier, hot melt extrusion process and downstream processing parameters on the moisture sorption properties of amorphous solid dispersions.
    Feng X; Vo A; Patil H; Tiwari RV; Alshetaili AS; Pimparade MB; Repka MA
    J Pharm Pharmacol; 2016 May; 68(5):692-704. PubMed ID: 26589107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
    Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
    AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
    Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
    Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Plasdone
    Butreddy A; Sarabu S; Bandari S; Batra A; Lawal K; Chen NN; Bi V; Durig T; Repka MA
    AAPS PharmSciTech; 2021 Jun; 22(5):196. PubMed ID: 34184149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
    Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
    Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
    Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
    J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
    Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
    Petrovick GF; Kleinebudde P; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tableting of hot-melt coated paracetamol granules: Material tableting properties and quality characteristics of the obtained tablets.
    Milanovic A; Aleksic I; Ibric S; Parojcic J; Cvijic S
    Eur J Pharm Sci; 2020 Jan; 142():105121. PubMed ID: 31669762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.